|[May 05, 2014]
Z-Medica Bolsters Hemostatic Product Line with Acquisition of Novacol®
WALLINGFORD, Conn. --(Business Wire)--
Z-Medica, a leading developer and marketer of hemostatic agents, today
announced that they have signed a definitive agreement with TAUREON,
headquartered in The Netherlands, to acquire Novacol®, a Class III
resorbable hemostatic product.
Novacol is currently sold in Europe and South Korea. Z-Medica will
continue to support that marketing strategy while making plans to expand
the product offering into other countries.
"Given our QuikClot portfolio of hemostatic dressings, it was a natural
fit for us to augment both our product line and our international
presence with Novacol," said Z-Medica's President and CEO Stephen J.
Fanning. "Our current products are gauze-based and non-resorbable.
Acquiring Novacol, which is a resorbable hemostat, is the first step
towards expanding the Z-Medica portfolio and providing a wider range of
innovative, safe, and effective products to the broader healthcare
Used primarily in surgeries, Novacol is comprised of 100% high-quality,
purified, natural long and short collagen fiber, which is resorbed by
the body. The product is available as the soft, pliable Novacol® Pad,
and Novacol® Fibrillar for use in cavities and irreular surfaces.
"Novacol is an effective product that will benefit from Z-Medica's
global distribution network," said TAUREON CEO Dick van Kalkeren.
"Z-Medica's experience with QuikClot and their reputation as a leader in
the hemostatic market ensures that Novacol will be able to compete
favorably in the market. The transfer of Novacol also enables TAUREON to
strengthen our focus in Europe on plastic and orthopedic surgery, human
tissue and advanced wound care."
Z-Medica, LLC is a medical device company founded in 2002, developing
fast acting, easy to use, hemostasis products that stop bleeding
wherever it occurs, making it possible to save lives and improve patient
outcomes. Based on tests conducted by the Naval Medical Research Center
and the U.S. Army Institute for Surgical Research, the Committee on
Tactical Combat Casualty Care (CoTCCC) recommended QuikClot Combat
Gauze® as the hemostatic agent for the Department of Defense and for use
by all U.S. military forces as the first line hemostatic agent for
traumatic bleeding. QuikClot products are developed and manufactured in
the United States. Z-Medica, LLC is a privately-held company based in
Wallingford, CT. For more information, visit www.z-medica.com.
TAUREON has become a well-known and trusted company in the field of
surgical specialties and advanced wound care products. You may be
familiar with us because of our products such as HoneySoft® (both Skin
Recovery Cream -SRC- and dressing) and SurfaSoft®. All these products
have been developed by TAUREON and as IP-holder TAUREON is authorized to
market them worldwide. However, TAUREON is also the holder of a vast
portfolio of surgical license products in The Netherlands and/or other
European countries, (like the Tutogen Biomaterials, BRAVA, the Avance
nerve graft, etc.) and advanced wound care products (like Omiderm,
Elasto-Gel, Hyiodine, HydroAid, etc.) and other quality products for
which TAUREON owns the exclusive marketing rights in specific European
[ Back To TMCnet.com's Homepage ]